MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

LB PHARMACEUTICALS INC (LBRX)

LB PHARMACEUTICALS INC (LBRX)

|||

Balance Sheets Overview

Current Ratio
1507.81%
Quick Ratio
1507.81%
Cash Ratio
1201.46%
Debt to Asset Ratio
8.11%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
283,111
320,676
250,173
269,744
Marketable securities
44,679
44,960
45,040
44,735
Prepaid expenses and other current assets
27,511
23,438
13,219
1,922
Total current assets
355,301
389,074
308,432
316,401
Operating lease right-of-use assets, net
3,405
2,101
2,151
2,198
Property and equipment
2,803
2,033
2,001
1,972
Less accumulated depreciation
599
502
420
337
Property and equipment, net
2,204
1,531
1,581
1,635
Restricted cash
782
776
770
512
Total assets
361,692
393,482
312,934
320,746
Accounts payable
3,491
7,119
2,127
2,590
Accrued expenses
19,229
3,057
4,585
3,327
Operating lease liabilities, current
844
730
730
730
Total current liabilities
23,564
10,906
7,442
6,647
Derivative liability - warrants
1,408
1,143
1,343
942
Operating lease liabilities, noncurrent
4,373
2,740
2,839
2,936
Total liabilities
29,345
14,789
11,624
10,525
Preferred stock , value-Series Seed Preferred Stock
-
-
0
0
Preferred stock , value-Series APreferred Stock
-
-
0
0
Preferred stock , value-Series BPreferred Stock
-
-
0
0
Preferred stock , value-Series CPreferred Stock
-
-
0
0
Common stock, 0.0001 par value, 500,000,000 shares authorized, 28,681,063 and 25,299,372 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
3
3
3
3
Additional paid-in capital
532,343
527,064
430,667
428,327
Accumulated deficit
-200,185
-148,582
-129,528
-118,056
Accumulated other comprehensive income
186
208
168
-53
Total stockholders' equity
332,347
378,693
301,310
310,221
Total liabilities and stockholders' equity
361,692
393,482
312,934
320,746
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$283,111K Marketable securities$44,679K Prepaid expenses andother current assets$27,511K Property and equipment$2,803K Total current assets$355,301K Operating leaseright-of-use assets, net$3,405K Property and equipment,net$2,204K Restricted cash$782K Less accumulateddepreciation$599K Total assets$361,692K Total liabilities andstockholders' equity$361,692K Total stockholders'equity$332,347K Total liabilities$29,345K Accumulated deficit-$200,185K Additional paid-in capital$532,343K Total currentliabilities$23,564K Operating leaseliabilities, noncurrent$4,373K Derivative liability -warrants$1,408K Accumulated othercomprehensive income$186K Common stock, 0.0001par value,...$3K Accrued expenses$19,229K Accounts payable$3,491K Operating leaseliabilities, current$844K